Another study from the EurHeCaLT database, analyzing 306 Milan criteria IN and 116 Milan criteria OUT patients, found that an AFP slope >15 ng/mL/month and mRECIST tumor progression were independent predictors of HCC recurrence and post-LT mortality, regardless of the Milan criteria status [19]. The gene discussed is AFP; the disease is hepatocellular carcinoma.